.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019979

« Back to Dashboard
NDA 019979 describes TICLID, which is a drug marketed by Roche Palo and is included in one NDA. Additional details are available on the TICLID profile page.

The generic ingredient in TICLID is ticlopidine hydrochloride. There are nine drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the ticlopidine hydrochloride profile page.

Summary for NDA: 019979

Tradename:
TICLID
Applicant:
Roche Palo
Ingredient:
ticlopidine hydrochloride
Patents:0
Therapeutic Class:Blood Products/Modifiers/ Volume Expanders
Formulation / Manufacturing:see details

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength125MG
Approval Date:Mar 24, 1993TE:RLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength250MG
Approval Date:Oct 31, 1991TE:RLD:No

Expired Orange Book Patents for NDA: 019979

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Roche Palo
TICLID
ticlopidine hydrochloride
TABLET;ORAL019979-001Mar 24, 19934,051,141► subscribe
Roche Palo
TICLID
ticlopidine hydrochloride
TABLET;ORAL019979-002Oct 31, 19914,591,592► subscribe
Roche Palo
TICLID
ticlopidine hydrochloride
TABLET;ORAL019979-002Oct 31, 19914,051,141► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc